Manufacturing and Production

Showing 15 posts of 5867 posts found.

GSK picture

GSK recalls Novartis’ blood pressure drug

February 28, 2012 Manufacturing and Production DynaCirc CR, GSK, Novartis

GlaxoSmithKline is the latest company to be affected by manufacturing glitches at Novartis’ troubled facility in Lincoln, Nebraska, having been …

EMA confirms verdict on Ben Venue facility

February 28, 2012 Manufacturing and Production Ben Venue, CHMP, EMA, Sanofi

The European Medicines Agency has officially removed Ben Venue Laboratories’ troubled Bedford facility as an approved location for the manufacture …
Shire image

Shire’s Vpriv plant wins EU approval

February 28, 2012 Manufacturing and Production EMA, Shire, Vpriv

Shire has been told by the European Medicines Agency that it can make use of a manufacturing facility in Lexington, …
Lilly picture

Lilly plans €330m biomanufacturing plant in Ireland

February 28, 2012 Manufacturing and Production Abbott, Ireland, Kinsale, lilly

There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …

Endo says Opana ER supply disruption will be temporary

February 28, 2012 Manufacturing and Production Endo, Novartis, Opana ER

Endo Pharmaceuticals has said that current supply restrictions for its new Opana ER formulation of oxymorphone are likely to be …

Priorclave Introduce Autoclave Application Selector at Arab Lab

February 27, 2012 Manufacturing and Production

It is not unexpected to find that senior managers from British autoclave manufacturer Priorclave will be making their way East …

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …
Genzyme picture

Genzyme to close UK site

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …

The NHS, a postcard from the frontline

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …

Astellas hires senior vice president for new Global Medical Affairs organisation

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations …

Alex Gorsky named new chief executive of J&J

February 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Georg Toufar

Working Life: Georg Toufar, director, Mundipharma

February 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Georg Toufar, Mundipharma, Working Life

Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT).  …
Teva image

MHRA suspends Teva licence for levothyroxine generic

February 21, 2012 Manufacturing and Production MHRA, Numark, Teva, levothyroxine

The UK medicine regulatory authority has suspended the licence for a levothyroxine product sold by Teva on the grounds that …

Asymchem plans additional investment in Dunhua facility

February 21, 2012 Manufacturing and Production Asymchem, China, Dunhua, manufacturing

China’s Asymchem Laboratories says it plans to invest another $12 million in its recently-opened manufacturing facility in Dunhua, Jilin province, …
The Gateway to Local Adoption Series

Latest content